SPINAL MUSCULAR ATROPHY

IN ADULTS

Eventually your adult spinal muscular atrophy (SMA) patients may not be able to scroll down this page. SMA is a debilitating neuromuscular disease characterised by motor neuron degeneration and loss of muscle strength.1 The loss of basic motor functions will require appropriate intervention.

The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.

SMA IN ADULTS

SIGNS AND SYMPTOMS

Is one of your teenager or adult patients reporting muscle weakness? Less severe forms of SMA can emerge and be diagnosed in adulthood.1,2 Compared to childhood SMA, adult SMA may have milder symptoms, but is still progressive. Compared to SMA in childhood, the course of SMA in adults can be more insidious and difficult to recognise.3

SMA IN ADULTS

DISEASE IMPACT

SMA is a disease that will keep on progressing without proper intervention.4 SMA impacts the lives of patients, gradually making them more and more reliant on others to do small things for them – bringing their lives to a standstill.

SMA IN ADULTS

CARE APPROACHES

The needs of people with SMA have evolved. Along with it much has changed in the quality of care and care approaches offered to them. Research into the underlying mechanisms of SMA has transformed the understanding of the disease and led to updated standards of care in terms of support and care options.5-7

SMA IN ADULTS

NEW POSSIBILITIES IN SMA

Many adults living with SMA lead fulfilling and productive lives. And now that supportive care is improving and the therapeutic landscape is changing, care expectations are even greater.8

The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families.
Photographs are for illustrative purposes only.

There are new possibilities for adults living with SMA. 

At Biogen, we are committed to supporting those with spinal muscular atrophy and their care teams. Our hope for Together in SMA is that by providing educational materials and resources, we can help you tackle the challenges your SMA patients face.

Together in SMA was created in support of that unity, and with the goal of becoming a valued tool for members of the team. Here you’ll find clinical information and care strategies that some people use to help manage the disease.

Biogen is building on our legacy of rare disease research and development to explore potential treatment options. And even then, we’ll still be together in SMA.

References

1. Montes J. Spinal Muscular Atrophy in Adults. [online] [cited 2020 Nov 30]. Available from: URL: https://neuropt.org/docs/degenerative-diseases-sig/spinal-muscular-atrophy-in-adults.pdf?sfvrsn=8d2aae96_2.

2. Juntas Morales R, Pageot N, Taieb G, Camu W. Adult-onset spinal muscular atrophy : and update. Rev Neurol (Paris) 2017;173(5):308-19.

3. Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007;22(8):1027-49.

4. Kaufmann P, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurol 2012;79:1889-1897.

5. Mercuri E, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscl Disord 2018;28(2):103-115.

6. Finkel R, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 2018;28(3):197-207.

7. Bharucha-Goebel D, Kaufmann P. Treatment Advances in Spinal Muscular Atrophy. Curr Neurol Neurosci Rep 2017;17(11):91.

8. Wan HWY, et al. “Getting ready for the adult world”: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis 2019;14:74.

9. Rouault F, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord 2017;27(5):428-438.